Document Type
Case Summary
Publication Date
3-2021
Case Synopsis
The Court held that plaintiffs’ strict product liability, breach of implied warranty, and deceptive trade practices claims against propofol drug manufacturers were preempted by federal law because it would have been impossible for them to comply with federal law and avoid state tort liability. The plaintiffs’ negligence claim, however, was not preempted because the manufacturers could have avoided state liability without violating of federal law.
Recommended Citation
Bacher, Mia, "Teva Parenteral Meds., Inc. v. Dist. Court, 137 Nev. Adv. Op. 6 (Mar. 4, 2021)" (2021). Nevada Supreme Court Summaries. 1387.
https://scholars.law.unlv.edu/nvscs/1387
COinS